powered by centersite dot net
Medications
Resources
Basic InformationLatest News
Few Older Patients Aware of DeprescribingHealth Tip: Medication Suggestions for Older AdultsPhysicians Tweeting About Drugs May Have Conflict of InterestWhite Kids More Likely to Get Unneeded AntibioticsNew Cholesterol Drugs Vastly Overpriced, Study ContendsFDA May Limit 'Risk Info' in Direct-to-Consumer TV Drug AdsHealth Tip: Throwing Out Leftover MedicineFDA Announces Recall of Some Liquid Pharmaceutical ProductsIs FDA Taking Close Enough Look at Fast-Tracked Drugs?U.S. Antidepressant Use Jumps 65 Percent in 15 YearsThe Fine Print on Medication Expiration DatesAmericans Taking More Prescription Drugs Than Ever: SurveyInappropriate Med Use High in Cognitively Impaired SeniorsA Reminder That Meds and Grapefruit Don't Always MixAspirin Responsiveness Can Change After Bariatric SurgerySome Medicines Boost Sensitivity to SunPainkiller Prescriptions More Prone to Errors If HandwrittenMedication Mistakes Have Doubled in U.S. Since 2000: StudyMarket Competition Linked to Change in Generic Drug PricesIs Your Child's 'Penicillin Allergy' Real?FDA Seeks to Increase Number of Generic Drugs on MarketWhen Is an Opioid Safe to Take?Lifesaving Drugs From Pfizer in Short Supply: FDALeading U.S. Doctors' Group Takes Aim at Rising Drug PricesU.S. Hospitals Still Prescribe Too Many Antibiotics: StudyBirth Control Pills Recalled Due to Danger of Unintended PregnancyNew Drugs Show Promise as First to Prevent MigraineMedication Adherence Up With Refill Synchronization ModelModified Vancomycin May Help Fight Bacterial ResistanceScientists Tweak Antibiotic to Boost Power Against 'Superbugs'New Cholesterol Fighting Meds Target Key GeneResearchers Say PDE5 Inhibitors Don't Cause MelanomaNearly a Third of Drugs Hit by Safety Issues After FDA ApprovalU.S. Moves to Avert Shortage of Yellow Fever VaccineOpioid Use by Iraq, Afghanistan War Vets Mirrors Rest of U.S.: StudyApril 29 Is National Prescription Drug Take Back DayERs Administering More Medications IntranasallyFDA Warns Against Children Taking Codeine, TramadolPhysicians Finding Ways to Work Around Cost of Rx MedicationsRuling Out Penicillin Allergy by Testing Inpatients Saves MoneyEpiPen Out-of-Pocket Costs More Than Doubled Over DecadeAACR: Regular Aspirin Use Linked to Lower Cancer MortalityFDA Approves Noctiva Nasal Spray for Nocturnal PolyuriaFDA Approves Odactra for House Dust Mite AllergiesHow Much Melatonin Is Really in That Supplement?Antidepressant Efficacy Varies for Depressive Symptom ClustersDo You Need an Antibiotic?'Off-Label' Antidepressants Common, But Where's the Evidence?Docs More Likely to Prescribe Antibiotics If Patients Expect ThemSimilar Adverse Event Risk for Typical, Atypical Antipsychotics
Questions and AnswersVideosLinksBook Reviews
Related Topics

Anxiety Disorders
Depression: Depression & Related Conditions
Mental Disorders
Mental Health Professions

FDA Announces Recall of Some Liquid Pharmaceutical Products

HealthDay News
by -- HeatlthDay staff
Updated: Aug 16th 2017

new article illustration

WEDNESDAY, Aug. 16, 2017 (HealthDay News) -- The U.S. Food and Drug Administration has announced a recall of numerous liquid pharmaceutical products because of possible bacterial contamination that could cause severe infections in vulnerable patients.

The drugs and dietary supplements, made by PharmaTech LLC in Davie, Fla., include liquid stool softeners, liquid vitamin D drops and liquid multivitamins marketed for infants and children, the agency said in a news release.

Reports of the discovery of Burkholderia cepacia bacteria in both Diocto Liquid and Diocto Syrup prompted the voluntary recall by three companies that label PharmaTech products, the FDA said. The three companies are Rugby Laboratories, Major Pharmaceuticals and Leader Brands.

"B. cepacia poses a serious threat to vulnerable patients, including infants and young children who still have developing immune systems," FDA Commissioner Dr. Scott Gottlieb said in a statement.

"These products were distributed nationwide to retailers, health care facilities, pharmacies and sold online -- making it important that parents, patients and health care providers be made aware of the potential risk and immediately stop using these products," Gottlieb added.

The bacteria pose the greatest danger to hospitalized patients, critically ill patients and people with health problems such as weakened immune systems and chronic lung diseases, according to the U.S. Centers for Disease Control and Prevention.

Signs of infection can range from no symptoms at all to serious respiratory infections, the CDC said. The bacteria can spread from person to person by direct contact and is often resistant to common antibiotics.

The FDA advises patients and physicians to stop using these products immediately. Consumers with questions can contact Rugby Laboratories/Major Pharmaceuticals at 800-645-2158, or Leader at 800-200-6313.

More information

Here is the FDA's complete list of the recalled products.